返回 Agenda
Session Chair(s)
Hilary Mandler, PHARMD
Sr Dir, med strategy
Supernus Pharmaceuticals, United States
Learning Objective : At the conclusion of this session, participants should be able to: - Recognize the high compliance risk areas for MSLs based upon recent CIAs - Discuss the impact of compliance and risk mitigation on the evolution of the MSL role and scientific engagement models - Identify three key compliance driven attributes you should consider when evaluating and selecting a customer engagement system
Speaker(s)
Faculty
Krystene Woodard, PHARMD
SHIRE, United States
Associate Director, Behavioral Health MSL Team
Faculty
Hilary Mandler, PHARMD
Supernus Pharmaceuticals, United States
Sr Dir, med strategy
Faculty
Chris Paap, PHARMD
Pfizer Inc - Medicines Development Group, United States
Team Leader/Senior Director Vaccines & Infectious Diseases Field Based Medical